Copertina

Harnessing mass spectrometric methods for exquisite allergen product characterization

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Marek Jutel, Magdalena Zemelka‐Wiacek, Oliver Pfaar
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Allergy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Algorithms in Allergy: Assessment of Rhinitis Using Allergen Exposure Chambers
di: Marek Jutel, et al.
Pubblicazione: (2024)

Clinical validation of grass pollen exposure chamber in patients with allergic rhinitis triggered by timothy grass
di: Anna Kosowska, et al.
Pubblicazione: (2024)

The Impact of War on Asthma, a Systematic Review and Meta‐Analysis: An EAACI Task Force Report
di: João Cavaleiro Rufo, et al.
Pubblicazione: (2025)

The Earlier the Merrier—But How?
di: Thomas Eiwegger, et al.
Pubblicazione: (2026)

Indoor and outdoor pollutants—No safe amount of air to breathe in
di: Ioana Agache, et al.
Pubblicazione: (2024)

Digitally‐enabled, person‐centred care (PCC) in allergen immunotherapy: An ARIA‐EAACI Position Paper
di: Oliver Pfaar, et al.
Pubblicazione: (2024)

House dust mite SCIT reduces asthma risk and significantly improves long‐term rhinitis and asthma control—A RWE study
di: Marek Jutel, et al.
Pubblicazione: (2024)

Quality control of allergen products with mass spectrometry part I: Positioning within the EU regulatory framework
di: Jelena Spiric, et al.
Pubblicazione: (2024)

Preventive allergen immunotherapy with inhalant allergens in children
di: Varsha Dwivedi, et al.
Pubblicazione: (2024)

Trace Elements in Allergy: Narrative Review
di: Michal Ordak, et al.
Pubblicazione: (2026)

EAACI Guidelines on Environmental Science for Allergy and Asthma—Recommendations on the Impact of Indoor Air Pollutants on the Risk of New‐Onset Asthma and on Asthma‐Related Outcomes
di: Ioana Agache, et al.
Pubblicazione: (2025)

A One‐Strength Dose Escalation Regimen for Birch Pollen SCIT Is Safe and Tolerable in Children, Adolescents, and Adults
di: Marek Jutel, et al.
Pubblicazione: (2026)

One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable
di: M. Jutel, et al.
Pubblicazione: (2024)

The first plant allergen to be cloned—the story of the major birch pollen allergen Bet v 1
di: Heimo Breiteneder
Pubblicazione: (2024)

A recent patent in allergy & immunology: Biomarkers on allergen‐specific memory B cells to predict allergen immunotherapy outcome
di: Menno C. van Zelm, et al.
Pubblicazione: (2024)

Algorithms in Allergy: General Allergen Molecule‐Based Algorithm for Allergen‐Specific Immunotherapy
di: Huey‐Jy Huang, et al.
Pubblicazione: (2026)

Early expansion of allergen‐responsive LAP+ B regulatory cells in allergic rhinitis but not in allergic asthma subjects during allergen immunotherapy
di: Astrid L. Voskamp, et al.
Pubblicazione: (2024)

Four years into the COVID‐19 pandemic: Timely published articles for patient care and EAACI's leadership role
di: María José Torres, et al.
Pubblicazione: (2024)

Identification of fructose‐bisphosphate aldolase as new pollen allergens
di: Le‐Bin Song, et al.
Pubblicazione: (2024)

Patterns of allergen recognition in Ligustrum polysensitized patients: An immunoproteomics approach
di: Raúl Porras‐Gutiérrez‐de‐Velasco, et al.
Pubblicazione: (2024)

Nasal allergen‐neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis
di: Ibon Eguiluz‐Gracia, et al.
Pubblicazione: (2024)

Identification of allergens from Aspergillus fumigatus—Potential association with lung damage in asthma
di: Eva‐Maria Rick, et al.
Pubblicazione: (2024)

Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice
di: Mia Hamilton Jee, et al.
Pubblicazione: (2024)

Expansion of phenotypically modified type 2 memory B cells after allergen immunotherapy
di: Anouk von Borstel, et al.
Pubblicazione: (2024)

Chicken meat allergy in children: Complex sensitization profiles with newly described allergen candidates
di: T. Guiddir, et al.
Pubblicazione: (2024)

Maximizing safety of ultrasound‐guided intralymphatic allergen administration in the superficial inguinal lymph node
di: Min‐Jeong Cho, et al.
Pubblicazione: (2024)

Reply to correspondence: Correspondence to “The impact of indoor pollution on asthma‐related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma”
di: Carlos Canelo‐Aybar, et al.
Pubblicazione: (2024)

Lupin, a potential “hidden” food anaphylaxis allergen: An alert from the Allergy‐Vigilance Network®
di: Guillaume Pouessel, et al.
Pubblicazione: (2024)

Tissue levels of Alternaria allergen Alt a 1 reflect recurrence of refractory airway diseases
di: Yui Miyabe, et al.
Pubblicazione: (2024)

Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force
di: Pablo Rodríguez del Río, et al.
Pubblicazione: (2024)

Induction of tolerance to food allergens—Younger is better
di: Johanna M. Smeekens, et al.
Pubblicazione: (2025)

Development of a low allergenic product for patients with milk allergy and assessment of its specific IgE reactivity
di: Duygu Yazici, et al.
Pubblicazione: (2024)

Pets, furry animal allergen components, and asthma in childhood
di: Katariina Lajunen, et al.
Pubblicazione: (2024)

The SQ tree sublingual immunotherapy tablet is effective and well tolerated in children—A pivotal phase III trial
di: Monika Gappa, et al.
Pubblicazione: (2024)

Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approach
di: Oliver Pfaar, et al.
Pubblicazione: (2025)

Proteomic approach to investigate allergens involved in severe walnut allergy
di: Satoshi Mochizuki, et al.
Pubblicazione: (2026)

Exploration of severity‐associated peanut allergens via proteomic analysis
di: Teruaki Matsui, et al.
Pubblicazione: (2025)

Reply to correspondence: “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”
di: Peter Bager, et al.
Pubblicazione: (2024)

Meta‐Analysis of PQ Grass 27600 SU Efficacy and Quality of Life From Phase III Trials
di: Stefan Zielen, et al.
Pubblicazione: (2025)

Precautionary allergen labels and socioeconomic disparities among food allergy caregivers
di: Grace Rabinowitz, et al.
Pubblicazione: (2025)